|
Volumn 15, Issue 3, 2001, Pages 146-154
|
Information and competency for consent to pharmacologic clinical trials in Alzheimer disease: An empirical analysis in patients and family caregivers
|
Author keywords
Alzheimer disease; Clinical trials; Competency; Ethics; Informed consent; Physician patient relations
|
Indexed keywords
HEPTYLSTIGMINE TARTRATE;
SELEGILINE;
ADULT;
AGE;
AGED;
ALZHEIMER DISEASE;
ARTICLE;
CAREGIVER;
CLINICAL RESEARCH;
COGNITIVE DEFECT;
COMPETENCE;
CONTROLLED STUDY;
DECISION MAKING;
DOCTOR PATIENT RELATION;
EDUCATION;
FAMILY;
FEMALE;
HUMAN;
INFORMED CONSENT;
MAJOR CLINICAL STUDY;
MALE;
PREDICTION;
PRIORITY JOURNAL;
RELIABILITY;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
EMPIRICAL APPROACH;
AGE FACTORS;
AGED;
AGED, 80 AND OVER;
ALZHEIMER DISEASE;
CLINICAL TRIALS;
DEMENTIA;
EDUCATIONAL STATUS;
ETHICS, MEDICAL;
FEMALE;
HUMANS;
INFORMED CONSENT;
MALE;
MENTAL COMPETENCY;
MENTAL STATUS SCHEDULE;
MIDDLE AGED;
PATIENT PARTICIPATION;
PHYSICIAN-PATIENT RELATIONS;
PREDICTIVE VALUE OF TESTS;
|
EID: 0034876670
PISSN: 08930341
EISSN: None
Source Type: Journal
DOI: 10.1097/00002093-200107000-00006 Document Type: Article |
Times cited : (39)
|
References (45)
|